A Cannabinoid Hypothesis of Schizophrenia: How Cannabis May Trigger Psychosis
A proposed "cannabinoid hypothesis" of schizophrenia describes multiple pathways through which THC may trigger psychosis, paralleling existing dopamine, serotonin, and glutamate hypotheses.
Quick Facts
What This Study Found
The review describes several putative pathways from cannabis to psychosis, integrating evidence about the endocannabinoid system, THC's effects on dopamine and glutamate signaling, and the connection between cannabis use and first-episode psychosis.
Key Numbers
Hypothesis parallels existing dopamine, serotonin, and glutamate hypotheses of schizophrenia
How They Did This
Narrative review synthesizing evidence about the endocannabinoid system, THC's neurochemical effects, and epidemiological links between cannabis and psychosis to propose a unified cannabinoid hypothesis.
Why This Research Matters
Understanding the specific biological pathways through which cannabis may trigger psychosis could enable targeted prevention strategies for susceptible individuals.
The Bigger Picture
Just as stimulant-induced psychosis led to the dopamine hypothesis and psychedelic-induced states led to the serotonin hypothesis, cannabis-induced psychosis may reveal a distinct endocannabinoid pathway to schizophrenia.
What This Study Doesn't Tell Us
Narrative review proposing a hypothesis rather than testing one. Pathways described are "putative" and not fully established.
Questions This Raises
- ?Can genetic variation in the endocannabinoid system identify who is most vulnerable to cannabis-induced psychosis?
- ?Would targeted interventions based on these pathways prevent schizophrenia in at-risk cannabis users?
Trust & Context
- Key Stat:
- Multiple putative pathways from cannabis to psychosis identified
- Evidence Grade:
- Narrative review proposing a hypothesis based on existing evidence rather than presenting new data.
- Study Age:
- Published in 2022
- Original Title:
- A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.
- Published In:
- Innovations in clinical neuroscience, 19(7-9), 38-43 (2022)
- Authors:
- Little, Rachel, D'Mello, Dale(2)
- Database ID:
- RTHC-04013
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
What is the cannabinoid hypothesis of schizophrenia?
It proposes that THC can trigger psychosis through multiple pathways involving the endocannabinoid system, similar to how other drug-induced psychotic states led to the dopamine and serotonin hypotheses of schizophrenia.
Does cannabis cause schizophrenia?
The review describes biological pathways through which cannabis could trigger psychosis in susceptible individuals, but having pathways does not mean everyone who uses cannabis will develop schizophrenia. Susceptibility likely involves genetic and environmental factors.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-04013APA
Little, Rachel; D'Mello, Dale. (2022). A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.. Innovations in clinical neuroscience, 19(7-9), 38-43.
MLA
Little, Rachel, et al. "A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.." Innovations in clinical neuroscience, 2022.
RethinkTHC
RethinkTHC Research Database. "A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psych..." RTHC-04013. Retrieved from https://rethinkthc.com/research/little-2022-a-cannabinoid-hypothesis-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.